Vitamin B9 (Folate) — Research Profile

Folic acid is the synthetic form found in supplements and fortified foods that must be converted through several enzymatic steps (including MTHFR) to become methylfolate (5-MTHF), the active form used in the body. An estimated 5-15% of the population has MTHFR polymorphisms (C677T, A1298C) that reduce this conversion by 30-70%. Methylfolate supplements bypass this entirely, providing the directly usable form.

Start folate supplementation at least 1-3 months before attempting conception, since neural tube closure occurs at 21-28 days post-conception — often before a woman knows she is pregnant. The CDC recommends all women of childbearing age consume 400 mcg daily regardless of pregnancy plans. During pregnancy, 600-800 mcg daily is recommended.

Methylfolate (5-MTHF) is a good choice if you have a known MTHFR polymorphism, are taking medications that affect folate metabolism, or want to avoid potential issues with unmetabolized folic acid. For most people without MTHFR variants, standard folic acid is effective and well-studied. Methylfolate costs more but eliminates any conversion concerns.

Synthetic folic acid is the most-researched form and is the basis of fortification and neural-tube-defect prevention data^[1]. 5-MTHF (L-methylfolate) is the biologically active form promoted for people carrying the MTHFR 677C>T variant that reduces folate conversion, but ODS does not establish it as superior for clinical outcomes. For most purposes folic acid is a well-documented, reasonable choice.

The best-established benefit is preventing neural tube defects: women who could become pregnant are advised to take 400 to 800 mcg of folic acid daily starting at least 1 month before conception, because the neural tube closes on days 21 to 28. Folate also corrects the megaloblastic anemia caused by folate deficiency. Folic acid (with vitamin B12) lowers blood homocysteine and reduces stroke risk in low-folate populations, but does not lower overall cardiovascular disease risk.

The adult RDA is 400 mcg DFE per day, rising to 600 mcg DFE in pregnancy and 500 mcg DFE during lactation. Women who could become pregnant are advised to get 400 mcg of folic acid daily from supplements or fortified foods, and those with a prior NTD-affected pregnancy are typically advised 4,000-5,000 mcg daily starting 1-3 months before conception under medical supervision. Do not exceed 1,000 mcg/day of folic acid without clinical guidance.

No specific time of day is established for folate. One absorption detail: synthetic folic acid is somewhat better absorbed on an empty stomach than with food (ODS counts it as 1 mcg DFE per 0.5 mcg folic acid fasting versus per 0.6 mcg taken with food), whereas naturally occurring food folate is unaffected. Any regular daily time is acceptable.

At recommended intakes folate produces few side effects. The notable safety issue is high-dose folic acid, which can mask vitamin B12 deficiency and leaves unmetabolized folic acid in the blood. Folate can also blunt the action of certain drugs such as methotrexate and some antiseizure medicines, which is a drug-interaction concern rather than a classic side effect.

Folate interacts with several drugs. It can reduce the effectiveness of methotrexate (patients using it for cancer should consult their oncologist first) and can lower serum levels of antiepileptics such as phenytoin, carbamazepine, and valproate, which in turn can deplete folate. Sulfasalazine inhibits folate absorption and can itself cause folate deficiency.

People who could become or are pregnant benefit most, since adequate folate before and in early pregnancy prevents neural tube defects ^[1]. Others who may need it include people with malabsorption conditions and those taking folate-depleting drugs like sulfasalazine or certain antiepileptics. Because high folic acid can mask B12 deficiency, anyone supplementing at higher doses should ensure adequate B12 intake as well.

ODS does not give a timeframe for how quickly folate corrects deficiency-related megaloblastic anemia or lowers homocysteine, so no reliable onset figure can be stated. For preventing neural tube defects the benefit is preventive rather than something you feel: folate must already be adequate before conception because the neural tube closes on days 21 to 28 after conception, which is why supplementation is advised starting at least 1 month before pregnancy.

Taking folate at the Recommended Dietary Allowance (400 mcg DFE daily for adults, 600 mcg DFE in pregnancy) carries no known risk with continued use. The main long-term concern is high-dose synthetic folic acid: intakes above the adult Tolerable Upper Intake Level of 1,000 mcg/day can mask the anemia of vitamin B12 deficiency while nerve damage progresses, and chronic high intake leaves unmetabolized folic acid in circulation. Staying at or near the RDA avoids both issues.

Yes, but the limit applies only to synthetic folic acid from supplements and fortified foods, not to folate occurring naturally in food. The adult Tolerable Upper Intake Level is 1,000 mcg/day (800 mcg at ages 14-18, 600 mcg at 9-13), set mainly because excess folic acid can correct the megaloblastic anemia of B12 deficiency without stopping the accompanying neurological damage.

Folate is routinely paired with vitamin B12 because high folic-acid intake can hide the blood signs of B12 deficiency, and taking B12 alongside it guards against missing that diagnosis. It has also been studied together with vitamins B6 and B12 in homocysteine-lowering trials, where the combination lowered homocysteine but did not reduce overall cardiovascular disease risk. No folate-specific combination is required for it to work.

Check that the amount is listed in mcg DFE (dietary folate equivalents), the unit U.S. labels use. The forms sold include synthetic folic acid and 5-MTHF (also labeled L-methylfolate or L-5-MTHF); folic acid is the most-studied form, while 5-MTHF is the already-reduced form marketed for people with reduced MTHFR activity. Match the dose to your need rather than buying the highest available strength.